This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Zrein, M Articles by Lacroix, M Search for Related Content PubMed PubMed Citation Articles by Zrein, M Articles by Lacroix, M

Comparison of a whole-virus enzyme immunoassay (EIA) with a peptide-based EIA for detecting rubella virus immunoglobulin G antibodies following rubella vaccination.

BioChem ImmunoSystems, Montréal, Québec, Canada.

ABSTRACT

A total of 250 human serum samples were tested for rubella virus immunoglobulin G antibodies by two enzyme immunoassays (EIAs), one using whole rubella virus antigen and the other based on the use of synthetic peptide antigen. The samples were taken from 125 volunteers before and after their immunization with the RA 27/3 rubella vaccine. This study indicates that a synthetic peptide-based EIA can favorably replace current viral lysate-based EIAs to detect rubella virus antibodies following immunization. Because the synthetic peptide used in this newly developed EIA represents a putative neutralization epitope of the rubella virus, it could also be instrumental in determining rubella immune status and in assessing vaccine program efficiency.

This article has been cited by other articles:

• Cordoba, P., Lanoel, A., Grutadauria, S., Zapata, M. (2000). Evaluation of Antibodies against a Rubella Virus Neutralizing Domain for Determination of Immune Status. CVI 7: 964-966 [Abstract] [Full Text]